62 participants
Semaglutide Delivered Epi-Intradermally by Microarray Patch (VX-201) Versus Subcutaneous Administration in Healthy Overweight and Obese Participants
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-31
- Start Date:
- 2026-06-15
- Completion:
- 2027-02-10
Conditions
- Overweight and/or Obesity
Interventions
- COMBINATION_PRODUCT
- DRUG
No Results Yet